Incyte | Umlaufvermögen

Aktienkurs
101.10
Täglich Wechseln
0.35 0.35%
Monatlich
-4.58%
Jährlich
43.57%
Q1 Prognose
97.97




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agenus USD 133.95M 120.61M 2025-09
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.54B 54M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


Incyte Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.